NGS-based testing is one of the most effective ways to track, slow, and prevent the spread of the SARS-CoV-2 virus. While Polymerase Chain Reaction (PCR) testing is more common, NGS-based testing has proved superior for its accuracy, sensitivity, and specificity. It can fully explain the origin, viral transmission, and evolution of strains, as well as whether a patient may have been impacted by coinfections. The intel on transmission helps public health officials zero in on outbreak clusters and, when applied widely, can inform on whether to implement or lift restrictions.
Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View customer spotlight videos
View Illumina webinars
View Illumina product videos
View Illumina support videos
